AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7655763
Drug: 12 g
RxNorm normalized name: PEG-12 GLYCERYL LAURATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 g piracetam i.v. (250 ml infusion over 30 minutes)
Trial: 7655763
Drug: 12 g
RxNorm normalized name: PEG-12 GLYCERYL LAURATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 g piracetam p.o. (60 ml sirup)
Trial: 2073165
Drug: Nitrendipine 20
RxNorm normalized name: nitrendipine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrendipine 20 mg OD
Trial: 6772199
Drug: Propranolol (320
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (320 mg total)
Trial: 6772199
Drug: Metoprolol (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (400 mg total)
Trial: 28523589
Drug: Alternating acetaminophen
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternating acetaminophen and ibuprofen (acetaminophen 10 mg/kg per dose with shortest interval of 4 h and ibuprofen 10 mg/kg per dose with shortest interval of 6 h; n=158)
Trial: 28523589
Drug: Acetaminophen monotherapy
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen monotherapy (10 mg/kg per dose with shortest interval of 4 h; n=158)
Trial: 28523589
Drug: Ibuprofen monotherapy
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen monotherapy (10 mg/kg per dose with shortest interval of 6 h; n=158)
Trial: 23789747
Drug: Postoperative PCA
RxNorm normalized name: lauryl PCA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative PCA with tramadol (20 mg) and metoclopramide (1 mg) per bolus
Trial: 23789747
Drug: Postoperative PCA
RxNorm normalized name: lauryl PCA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative PCA with morphine (1 mg) per bolus
Trial: 8666599
Drug: Aspirin alone
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin alone (Control)
Trial: 14990013
Drug: Rabeprazole (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole (10 mg twice daily) + Amoxicillin (1000 mg twice daily) + Clarithromycin (500 mg twice daily) for 1 week (RAC group)
Trial: 14990013
Drug: Rabeprazole (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole (10 mg twice daily) + Amoxicillin (1000 mg twice daily) + Metronidazole (400 mg twice daily) for 1 week (RAM group)
Trial: 9877365
Drug: Immunoglobulins extracted
RxNorm normalized name: immunoglobulin A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunoglobulins extracted from immunized bovine colostrum (IIBC) 10 g daily for 4 days
Trial: 9877365
Drug: Placebo preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo preparation (10 g daily for 4 days)
Trial: 30770745
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of resection, post-operative SRS/SFRT and SRS/SFRT to intact lesions
Trial: 27617368
Drug: Already prescribed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Already prescribed a respiratory medication
Trial: 23910581
Drug: Nesiritide therapy
RxNorm normalized name: nesiritide
DrugBank: Nesiritide (DB04899)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nesiritide therapy (0.006 μg kg(‐1) min(‐1))
Trial: 17412329
Drug: Soy protein
RxNorm normalized name: Soy Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy protein supplement
Trial: 15118618
Drug: 20 microg
RxNorm normalized name: Calcifediol 20 microgram oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 microg ethinyl estradiol + 100 microg levonorgestrel followed by 7 pill-free days
Trial: 15118618
Drug: 7-day pill-free
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-day pill-free interval
Trial: 11310514
Drug: Oral syringe
RxNorm normalized name: Oral Syringe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral syringe
Trial: 9141918
Drug: Left atrial
RxNorm normalized name: Echinacea, aerial parts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Left atrial administration of epinephrine at 100 ng.kg‐1.min‐1
Trial: 9141918
Drug: Right atrial
RxNorm normalized name: Echinacea, aerial parts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Right atrial administration of epinephrine at 100 ng.kg‐1.min‐1
Trial: 7894222
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight heparin (LMWH) and Unfractionated heparin
Trial: 3690032
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg almitrine
Trial: 27028316
Drug: Flurbiprofen 8.75
RxNorm normalized name: flurbiprofen 8.75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flurbiprofen 8.75 mg spray
Trial: 16796150
Drug: Fish-oil (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish-oil (4 g/day)
Trial: 16796150
Drug: Soy-oil (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy-oil (4 g/day)
Trial: 10799796
Drug: Postoperative pain
RxNorm normalized name: Dermoplast Pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative pain medications before educational program
Trial: 10799796
Drug: Postoperative pain
RxNorm normalized name: Dermoplast Pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative pain medications after educational program
Trial: 10799796
Drug: Cost of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cost of acute postoperative pain medication
Trial: 8638023
Drug: EP-guided antiarrhythmic
RxNorm normalized name: acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EP-guided antiarrhythmic drug therapy (propafenone, flecainide, disopyramide, sotalol, amiodarone)
Trial: 1597023
Drug: E5 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E5 2.5 mg/kg
Trial: 1597023
Drug: E5 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E5 7.5 mg/kg
Trial: 30314856
Drug: ACTI-BREAK intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ACTI-BREAK intervention (3×5min active breaks incorporated into classroom routine daily)
Trial: 24697278
Drug: Controlled-release cilostazol
RxNorm normalized name: Cilostazol
DrugBank: Cilostazol (DB01166)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Controlled-release cilostazol formulation
Trial: 24697278
Drug: Pletal (twice-daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pletal (twice-daily immediate-release formulation)
Trial: 20400005
Drug: Propofol 1.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 1.3 mg/kg
Trial: 20400005
Drug: Propofol 1.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 1.6 mg/kg
Trial: 20400005
Drug: Propofol 2.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 2.3 mg/kg
Trial: 16377698
Drug: BAL8557 (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAL8557 (100 mg of BAL4815)
Trial: 16377698
Drug: BAL8557 (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAL8557 (200 mg of BAL4815)
Trial: 16377698
Drug: BAL8557 (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAL8557 (400 mg of BAL4815)
Trial: 16377698
Drug: BAL8557 (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAL8557 (50 mg of BAL4815)
Trial: 10808172
Drug: Montelukast 10
RxNorm normalized name: montelukast 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast 10 mg with loratadine 10 mg
Trial: 8673937
Drug: Ketorolac oral
RxNorm normalized name: ketorolac Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac oral 10 mg at six hour intervals for 24 hours
Trial: 8673937
Drug: Ketorolac injectable
RxNorm normalized name: ketorolac Injectable Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac injectable 10 mg at the height/depth of the buccal vestibule of the tooth to be treated
Trial: 8673937
Drug: No assigned
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No assigned medication (control group)
Trial: 1633067
Drug: Frusemide 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Frusemide 60 mg as two oral controlled release (CR) formulations
Trial: 1633067
Drug: Plain tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plain tablets of Frusemide 60 mg
Trial: 6094278
Drug: Ketoconazole in
RxNorm normalized name: Product containing ketoconazole in oral dose form (medicinal product form)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoconazole in combination with chemical nail avulsion (group B)
Trial: 31250992
Drug: RPh201 (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RPh201 (5 mg, 10 mg, 20 mg) in SAD stage
Trial: 31250992
Drug: RPh201 (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RPh201 (5 mg, 10 mg, 20 mg) in MAD stage
Trial: 21821621
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of clinical items indicative of inflammatory back pain for diagnosing axial spondyloarthritis (SpA)
Trial: 21821621
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of clinical items indicative of inflammatory back pain
Trial: 11289194
Drug: Gatifloxacin 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gatifloxacin 600 mg
Trial: 11289194
Drug: Gatifloxacin 400
RxNorm normalized name: gatifloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gatifloxacin 400 mg and 600 mg, Ofloxacin 400 mg
Trial: 3606238
Drug: Subcutaneous closed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous closed suction drainage
Trial: 29044862
Drug: Vinorelbine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vinorelbine plus cisplatin chemotherapy
Trial: 27942103
Drug: Single-dose treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose treatment (5 mg/kg)
Trial: 27942103
Drug: Multiple doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple doses (1.7 mg/kg three times a day)
Trial: 12904894
Drug: Eniluracil (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eniluracil (20 mg orally twice daily)
Trial: 9356001
Drug: Aerosolized surfactant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerosolized surfactant (palmitoylphosphadidylcholine [DPPC]) 607.5 mg/d for 2 weeks
Trial: 3485390
Drug: Lidocaine, 1
RxNorm normalized name: Buffered Lidocaine, 1%-8.4% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine, 1 mg/kg intravenously 5 min before aortic unclamping and cardiac reperfusion, followed by infusion at 40 micrograms X kg‐1 X min‐1
Trial: 31924544
Drug: OPT-302 monotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OPT-302 monotherapy (2 mg)
Trial: 31924544
Drug: OPT-302 (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OPT-302 (2 mg) combined with ranibizumab (0.5 mg)
Trial: 29633644
Drug: KT‐11 food
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KT‐11 food tablet (1.2×10^10 KT‐11 cells)
Trial: 29633644
Drug: Placebo food
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo food tablet (without KT‐11)
Trial: 28689898
Drug: Prednisone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone (10 mg/day to 60 mg/day)
Trial: 16458545
Drug: Prednisone (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone (60 mg/day)
Trial: 28689898
Drug: Prednisone (35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone (35 mg/day)
Trial: 23334732
Drug: Alendronate (70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate (70 mg weekly) plus exercise (using ARED)
Trial: 23334732
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of exercise plus antiresorptive drug (alendronate)
Trial: 22008228
Drug: Metoclopramide (MTCP)
DrugBank: Metoclopramide (DB01233)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metoclopramide (MTCP) 20 mg IV
Trial: 22008228
Drug: Diphenhydramine (DPH)
DrugBank: Diphenhydramine (DB01075)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diphenhydramine (DPH) 50 mg IV
Trial: 8866496
Drug: Idebenone (antioxidant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Idebenone (antioxidant and enhancer of oxidative metabolism)
Trial: 1473740
Drug: Combination chlorambucil
RxNorm normalized name: Chlorambucil
DrugBank: Chlorambucil (DB00291)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combination chlorambucil and cisplatin
Trial: 1473740
Drug: Sequential chlorambucil
RxNorm normalized name: Chlorambucil
DrugBank: Chlorambucil (DB00291)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sequential chlorambucil followed by cisplatin on treatment failure
Trial: 29730918
Drug: Chemotherapy combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy combined with Ginseng Rg3
Trial: 27114413
Drug: Preoperative dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Preoperative dexamethasone (0.15 mg/kg before ESD)
Trial: 23015655
Drug: tesamorelin, 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tesamorelin, 2 mg once daily for 12 months
Trial: 30900658
Drug: Transdermal diclofenac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal diclofenac patch
Trial: 17331931
Drug: Placebo patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo patch (Control)
Trial: 16361616
Drug: Paclitaxel 225
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 225 mg/m2/3 h, carboplatin (AUC = 6), tirapazamine 260 mg/m2 (escalated to 330 mg/m2 in cycle 2 if tolerable)
Trial: 11532465
Drug: Low-dose oral
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose oral contraceptive containing 20 microg of ethinyl estradiol and 100 microg of levonorgestrel (LNG/EE)
Trial: 9468459
Drug: Diuretic (hydrochlorothiazide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diuretic (hydrochlorothiazide plus triamterene)
Trial: 9468459
Drug: Converting enzyme
RxNorm normalized name: Prohormone converting enzyme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Converting enzyme inhibitor (trandolapril)
Trial: 9468459
Drug: Calcium antagonist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium antagonist (amlodipine, added after 3 months if required)
Trial: 8181121
Drug: h-SOD (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: h-SOD (10 mg/kg intravenous bolus followed by 0.2 mg.kg-1.min-1 infusion)
Trial: 3310630
Drug: Sucralfate suspension
RxNorm normalized name: Sucralfate
DrugBank: Sucralfate (DB00364)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sucralfate suspension (n = 31)
Trial: 31670998
Drug: 17α-hydroxyprogesterone caproate
RxNorm normalized name: Hydroxyprogesterone Caproate
DrugBank: Hydroxyprogesterone caproate (DB06789)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 17α-hydroxyprogesterone caproate (250 mg/IM weekly until 37 weeks' gestation)
Trial: 25669920
Drug: Probiotic (Lactobacillus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic (Lactobacillus helveticus and Lactobacillus rhamnosus) low-dose (4 × 10(9) CFU/day)
Trial: 25669920
Drug: Probiotic (Lactobacillus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic (Lactobacillus helveticus and Lactobacillus rhamnosus) high-dose (8 × 10(9) CFU/day)
Trial: 23889923
Drug: Oral prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral prednisone as an add-on therapy to verapamil
Trial: 23889923
Drug: Monotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy with verapamil
Trial: 16231168
Drug: DHEA (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHEA (150 mg b.d. for 7 days)
Trial: 8711640
Drug: rhDNase 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhDNase 2.5 mg twice daily for 10 days
Trial: 1506213
Drug: Coal tar
RxNorm normalized name: Coal Tar
DrugBank: Coal tar (DB11082)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coal tar preparation applied twice weekly for 8 weeks (mode I)
Trial: 1506213
Drug: Coal tar
RxNorm normalized name: Coal Tar
DrugBank: Coal tar (DB11082)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coal tar preparation applied daily for 8 weeks (mode II)
Trial: 1506213
Drug: Coal tar
RxNorm normalized name: Coal Tar
DrugBank: Coal tar (DB11082)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coal tar preparation used under occlusion for 30 min every second day for 4 weeks (mode III)
Trial: 31006669
Drug: NT-pro-BNP levels
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NT-pro-BNP levels above 125 pg/ml, thrombocytopenia, atrial fibrillation/flutter
Trial: 20202002
Drug: Tamsulosin (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin (0.2 mg/day) for a maximum of 4 weeks
Trial: 17703640
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care / Unfractionated heparin
Trial: 16385658
Drug: Ketorolac 0.5
RxNorm normalized name: KETOROLAC 0.5/PHENYLEPHRINE2.5/PROPARACAINE0.5/TROPICAMIDE 1%OPH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac 0.5 mg/kg before the induction of anesthesia
Trial: 91483
Drug: THC 180-210
RxNorm normalized name: THC
DrugBank: Dronabinol (DB00470)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: THC 180-210 mg/day
Trial: 91483
Drug: THC 70-90
RxNorm normalized name: THC
DrugBank: Dronabinol (DB00470)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: THC 70-90 mg/day
Trial: 31120313
Drug: 10% lidocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% lidocaine ointment
Trial: 26455190
Drug: TXA (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TXA (10 mg/kg) injected intravenously approximately 10 minutes before tourniquet release
Trial: 23355148
Drug: Dexmedetomidine (loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (loading dose 1 μg kg(‐1) over 10 min, followed by constant intravenous infusion 0.7 μg kg(‐1) h(‐1))
Trial: 21393261
Drug: Ultrasound and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound and colour Doppler-guided sclerosing polidocanol injections
Trial: 11319482
Drug: Influenza vaccine
RxNorm normalized name: Influenza vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Influenza vaccine (trivalent subvirion vaccine, 15mg of surface antigens)
Trial: 7951402
Drug: Transdermal 17
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal 17 beta‐estradiol, 50 micrograms/day (Estraderm TTS 50) for 14 days, followed by transdermal combination of 17 beta‐estradiol (50 micrograms/day) and norethisterone acetate (NETA) 250 micrograms/day for the next 14 days (Group A)
Trial: 7951402
Drug: Transdermal 17
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal 17 beta‐estradiol, 50 micrograms/day (Estraderm TTS 50) for 28 days, adding oral medroxyprogesterone acetate (MPA), 10 mg/day, during the final 14 days (Group B)
Trial: 22759088
Drug: Pregabalin treatment
RxNorm normalized name: Pregabalin
DrugBank: Pregabalin (DB00230)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Pregabalin treatment for 40 days
Trial: 19751459
Drug: Amlodipine (AML)
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine (AML) + Olmesartan Medoxomil (OM) 5+40 mg/d
Trial: 19751459
Drug: Amlodipine (AML)
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine (AML) + Olmesartan Medoxomil (OM) 10+40 mg/d
Trial: 19751459
Drug: Amlodipine (AML)
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine (AML) + Olmesartan Medoxomil (OM) + Hydrochlorothiazide (HCTZ) 10+40+12.5 mg/d
Trial: 19751459
Drug: Amlodipine (AML)
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine (AML) + Olmesartan Medoxomil (OM) + Hydrochlorothiazide (HCTZ) 10+40+25 mg/d
Trial: 8277066
Drug: Intravenous anistreplase
RxNorm normalized name: Anistreplase
DrugBank: Anistreplase (DB00029)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous anistreplase (30 U) given at home
Trial: 8277066
Drug: Intravenous anistreplase
RxNorm normalized name: Anistreplase
DrugBank: Anistreplase (DB00029)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous anistreplase (30 U) given in the hospital
Trial: 26370515
Drug: Drug Coated
RxNorm normalized name: Drug coated stent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug Coated Balloon (DCB) angioplasty
Trial: 26231519
Drug: High Intensity
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High Intensity (HI) - Combination of MI1 and MI2 interventions
Trial: 23948351
Drug: Icotinib (125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Icotinib (125 mg, three times per day)
Trial: 23948351
Drug: Gefitinib (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gefitinib (250 mg, once per day)
Trial: 18950332
Drug: GA+CP group:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GA+CP group: GA with sevoflurane, combined with caudal anesthesia of plain Bupivacaine (1.25 ml x kg(‐1) of 0.2%)
Trial: 18950332
Drug: GA+CA group:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GA+CA group: sevoflurane GA combined with caudal anesthesia of epinephrine‐added Bupivacaine (1.25 ml x kg(‐1) of 0.2% Bupivacaine plus 1/200,000 epinephrine)
Trial: 31016447
Drug: iohexol 350
RxNorm normalized name: iohexol 350 mg/mL injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: iohexol 350 mg I/ml